Status:
UNKNOWN
Survival and Description of Care for Patients With Degenerate Vaterian Ampulloma
Lead Sponsor:
Federation Francophone de Cancerologie Digestive
Conditions:
Ampullary Adenocarcinoma
Eligibility:
All Genders
18+ years
Brief Summary
A Vater's ampulloma is a rare digestive tumour which accounts for under 1% of all digestive tumours. The only curative treatment is complete excision (surgical or endoscopic) of the lesions which is p...
Detailed Description
A Vater's ampulloma is a rare digestive tumour which accounts for under 1% of all digestive tumours. In terms of incidence, it is the 3rd most common biliary tract tumour after gallbladder cancer and ...
Eligibility Criteria
Inclusion
- Patients aged 18 years and older.
- Histologically-proven adenocarcinoma of the ampulla of Vater which is operable or with locoregional or metastatic recurrence after excision less than 6 months previously.
Exclusion
- Patients who cannot be followed up regularly for psychological, social, family or geographical reasons.
- Non-ampullary tumours.
- Non-adenocarcinomatous ampullary tumours.
- Ampullary adenocarcinomas which are metastatic or locally advanced from the outset and inoperable.
Key Trial Info
Start Date :
July 7 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 15 2022
Estimated Enrollment :
402 Patients enrolled
Trial Details
Trial ID
NCT03800212
Start Date
July 7 2017
End Date
December 15 2022
Last Update
March 24 2022
Active Locations (36)
Enter a location and click search to find clinical trials sorted by distance.
1
Ch D'Abbeville
Abbeville, France
2
Chu Hotel Dieu
Angers, France
3
Ch Annecy Genevois
Annecy, France
4
Ch Cote Basque
Bayonne, France